Andere talen NanoVibronix, Inc.

Aandelen

NAOV

US63008J6038

Beurs gesloten - Nasdaq Andere beurzen 22:30:01 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,736 ^USD	-0,54%		-2,97%	-36,00%

01/05	NanoVibronix kondigt PainShield aan als onderdeel van het Veteran Affairs? FSS contract	CI
08/04	NanoVibronix, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award	01/05
NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs? FSS Contract Award	01/05
NanoVibronix : Failure to Satisfy Listing Rule - Form 8-K	15/04
NanoVibronix Issues Letter to Stockholders	09/04
NanoVibronix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/04
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield	28/03
NanoVibronix Featured in Your Bladder Health Magazine	06/12
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity	04/12
NanoVibronix, Inc. Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity	04/12
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan	28/11
NanoVibronix, Inc. Signs Research Agreement for Clinical Study of UroShield with University of Michigan	28/11
NanoVibronix Regains Nasdaq Compliance	21/11
NanoVibronix Issues Letter to Shareholders	14/11
NanoVibronix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1	07/11
Investors Eye Fed Moves as US Futures Trend Lower in Friday's Premarket	20-10-23
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services Drug Tariff	28-09-23
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff	27-09-23
NanoVibronix, Inc. Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff	27-09-23
NanoVibronix Files Registration Statement on Behalf of Selling Shareholders	13-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen NanoVibronix, Inc.

Aandelen

NAOV

US63008J6038

Andere talen

Filters